Supply of Pharmaceutical Products
Original notice title
Bulgaria – Pharmaceutical products – Динамична система за покупки ДОСТАВКА НА ЛЕКАРСТВЕНИ ПРОДУКТИ ЗА НУЖДИТЕ НА „МБАЛ - БОТЕВГРАД“ ЕООД за период от 3 години
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
50 / 100
Risk factors
No procurement documents (technical specifications, draft contract, etc.) were provided for analysis. Key details on pr...
Structured data indicates EU funding (isEuFunded: true), but the XML notice states 'no-eu-funds'. This may affect award...
Restricted procedure — pre-qualification required
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- BGN 566.2k estimated value
- Dynamic Purchasing System (DPS)
- Supplies contract
- 1 lot
- Duration 36 MONTH
- Supply of pharmaceutical products (CPV 33600000) to MBAL-Botevgrad Hospital.
- DPS duration of 36 months.
Show full summary
This notice establishes a Dynamic Purchasing System (DPS) for the supply of pharmaceutical products to MBAL-Botevgrad Hospital in Bulgaria for a period of 3 years. The DPS is divided into a single lot covering all pharmaceutical products. The estimated total value is 566,202 BGN. The procedure is restricted, with award based on lowest price. Participation requires a wholesale authorization for medicinal products. The notice publication date is 2025-09-29, and the deadline for admission to the DPS is 2028-09-26. No procurement documents were analyzed.
Risks
No procurement documents (technical specifications, draft contract, etc.) were provided for analysis. Key details on pr...
Structured data indicates EU funding (isEuFunded: true), but the XML notice states 'no-eu-funds'. This may affect award...
Restricted procedure — pre-qualification required
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Must hold a wholesale authorization for medicinal products issued by the Bulgarian Drug Agency or equivalent.
Administrative
- Must submit an ESPD (European Single Procurement Document) with Part IV, Section A completed.
- Electronic submission via the CAIS EOP platform is required.
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Location
гр. Ботевград, BGR
Buyer profile
Identifier
000770022
Activity
Health
Lots (1)
LOT-0001
Supply of Pharmaceutical Products
Supply of various medicinal products to MBAL-Botevgrad Hospital over a 3-year period. Quantities are indicative and non-binding.
BGN 566.2k
Estimated value
Location
Duration
Category
Award Criteria
Deadline
Award details
Съгласно чл. 70, ал. 2, т. 1 ЗОП икономически най-изгодната оферта във втория етап на ДСП се определя въз основа на критерия "най-ниска цена".
Value note
Show original TED data
Original lot title
Динамична система за покупки ДОСТАВКА НА ЛЕКАРСТВЕНИ ПРОДУКТИ ЗА НУЖДИТЕ НА „МБАЛ - БОТЕВГРАД“ ЕООД за период от 3 години
Original TED description
Динамична система за покупки ДОСТАВКА НА ЛЕКАРСТВЕНИ ПРОДУКТИ ЗА НУЖДИТЕ НА „МБАЛ - БОТЕВГРАД“ ЕООД за период от 3 години Посочените количества по Техническата спецификация са прогнозни и не пораждат задължения за Възложителя да ги възложи в прогнозния обем. Фактическото изпълнение на обществената поръчка ще се определи на базата на реално доставените лекарствени продукти, в рамките на финансовия ресурс.
Procurement Details
- Publication date
- 28 Sep 2025
- Languages
- Bulgarian
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 633535-2025
Documents (1)
Similar tenders
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Belgium – Pharmaceutical products – Antimycotica
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
50 / 100
Risk factors
No procurement documents (technical specifications, draft contract, etc.) were provided for analysis. Key details on pr...
Structured data indicates EU funding (isEuFunded: true), but the XML notice states 'no-eu-funds'. This may affect award...
Restricted procedure — pre-qualification required
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications